Breast cancer progression: the devil is in the details
Wednesday, April 27, 2016 - 09:50
in Health & Medicine
Researchers describe how breast cancer cells challenged with a small-molecule inhibitor targeting specific invasive properties switch to an alternative mode-of-action, rendering them even more aggressive. The results may impair future therapeutic approaches in the TGF-beta pathway.